Open AccessThe Use of a Novel Alpha-Synuclein Binding Aptamer in Models of Parkinson’s Disease
Author(s) -
Katelyn Ventura
Publication year - 2022
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.22215/etd/2021-14868
Subject(s) - aptamer , alpha synuclein , in vivo , substantia nigra , genetically modified mouse , parkinson's disease , in vitro , transgene , neuroscience , dopaminergic , chemistry , pharmacology , medicine , microbiology and biotechnology , disease , biology , dopamine , pathology , biochemistry , gene , genetics